MINI FUTURE LONG - NOVOZYMES B Share Price

Certificat

DE000MB9UTN4

Market Closed - Börse Stuttgart 19:30:23 31/05/2024 BST
2.21 EUR -3.07% Intraday chart for MINI FUTURE LONG - NOVOZYMES B
1 month+15.71%
3 months+10.50%
Date Price Change
31/05/24 2.21 -3.07%
30/05/24 2.28 -0.44%
29/05/24 2.29 -8.03%
28/05/24 2.49 +0.81%
27/05/24 2.47 +2.49%

Delayed Quote Börse Stuttgart

Last update May 31, 2024 at 07:30 pm

More quotes

Static data

Product typeKnock-Out with Stop Loss
Buy / SellCALL
Underlying NOVONESIS A/S
Issuer Morgan Stanley
WKN MB9UTN
ISINDE000MB9UTN4
Date issued 16/08/2023
Strike 242.8 kr
Maturity Unlimited
Parity 10 : 1
Emission price 1.18
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 2.62
Lowest since issue 0.54

Company Profile

Novonesis A/S (formerly Novozymes A/S) is the world's leading producer of enzymes and microorganisms for industrial companies. Net sales break down by market as follows: - industry of cleaning and household maintenance products (28.5%); - bioenergy (24.8%); - food industry and human health (22.1%); - technical and cereal industries (12.8%): microorganisms used in the field of wastewater treatment, technical enzymes intended for the textile, leather, pulp and paper industries; - agriculture and animal feed industry (11.8%): enzymes used to improve the productivity and digestion of certain foods. Net sales are geographically distributed as follows: Denmark (1.3%), Europe/Middle East/Africa (33.5%), North America (33.9%), Asia/Pacific (18.5%) and Latin America (12.8%).
Sector
-
More about the company

Ratings for Novonesis A/S

Trading Rating
Investor Rating
ESG Refinitiv
B+
More Ratings

Consensus: Novonesis A/S

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
14
Last Close Price
408.6 DKK
Average target price
437.4 DKK
Spread / Average Target
+7.04%
Consensus